Pharmacogenomics in the Treatment of Mood Disorders: Strategies and Opportunities for Personalized Psychiatry

EPMA Journal - United Kingdom
doi 10.1007/s13167-017-0112-8
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Personalized Treatment in the Epilepsies: Challenges and Opportunities

Expert Review of Precision Medicine and Drug Development
Molecular MedicineDrug DiscoveryGeneticsPharmacology
2018English

Treatment-Resistant Mood Disorders

Revista de Psiquiatria Clinica
PsychiatryMental Health
2015English

Pharmacogenomics: Challenges and Opportunities

Annals of Internal Medicine
Internal MedicineMedicine
2006English

Personalized Antiplatelet and Anticoagulation Therapy: Pharmacogenomics

Japanese Journal of Thrombosis and Hemostasis
2019English

Inpatient Treatment for Mood Disorders – A Lost Opportunity?

Australian and New Zealand Journal of Psychiatry
MedicinePsychiatryMental Health
2015English

Consequences of CYP2D6 Copy-Number Variation for Pharmacogenomics in Psychiatry

Frontiers in Psychiatry
PsychiatryMental Health
2019English

Psychedelics in the Treatment of Unipolar Mood Disorders: A Systematic Review

Journal of Psychopharmacology
MedicinePsychiatryMental HealthPharmacology
2016English

Opportunities and Challenges Facing Biomarker Development for Personalized Head and Neck Cancer Treatment

Head and Neck
Otorhinolaryngology
2012English

A Review of Contingency Management for the Treatment of Substance-Use Disorders: Adaptation for Underserved Populations, Use of Experimental Technologies, and Personalized Optimization Strategies

Substance Abuse and Rehabilitation
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy